The Future of Stem Cell Therapy in Retina

Stem cell therapy may offer retina specialists a new avenue for regenerating damaged tissue in the back of the eye.

Read Article
  • Diabetic Macular Edema:

    Understanding and Implementing Findings From Protocol T

    Read Article
 

@RetinaToday

Injecting into eyes w/ an IMT can be risky. Review these tips from Brian Joondeph, MD, and Jon Zick to minimize risk: http://t.co/49nbGYZwm1

Articles From This Issue


 

The Future of Stem Cell Therapy in Retina

At a Glance • The eye is especially well suited for stem cell therapy. • There are two approaches to stem cell therapy: cell replacement therapy and regenera…

Pars Plana Vitrectomy: Beyond the OR

At a Glance • Retina surgeons in developing nations must consider socioeconomic factors when planning to perform pars plana vitrectomy in certain patients. • S…

 
DME

Uveitis Resource Center

advertisement

NEWS


 

Eylea (Aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion

Regeneron Pharmaceuticals announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, …

ONL Therapeutics Provides Update on Novel Photoreceptor Protection Platform for Retinal Diseases

ONL Therapeutics provided an update on the company’s ongoing drug development program to block…

Video Series


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Alan B. Guralnick
Publisher
484-581-1832
aguralnick@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.

Website Design by Sides Media